Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 Inhibitor fit in the management of type 2 diabetes?

Muhammad Abdulghani

Clinical Research

Research output: Contribution to journal › Comment/debate

34 Citations (Scopus)

Original language	English
Pages (from-to)	373-375
Number of pages	3
Journal	Diabetes care
Volume	38
Issue number	3
DOIs	https://doi.org/10.2337/dc14-2517
Publication status	Published - 1 Mar 2015

Access to Document

10.2337/dc14-2517

Link to publication in Scopus

Cite this

Abdulghani, M. (2015). Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 Inhibitor fit in the management of type 2 diabetes? Diabetes care, 38(3), 373-375. https://doi.org/10.2337/dc14-2517

@article{c69c79ec4ce24ffa8b08be39c88266be,

title = "Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 Inhibitor fit in the management of type 2 diabetes?",

author = "Muhammad Abdulghani",

year = "2015",

month = mar,

day = "1",

doi = "10.2337/dc14-2517",

language = "English",

volume = "38",

pages = "373--375",

journal = "Diabetes Care",

issn = "1935-5548",

publisher = "American Diabetes Association Inc.",

number = "3",

}

TY - JOUR

T1 - Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 Inhibitor fit in the management of type 2 diabetes?

AU - Abdulghani, Muhammad

PY - 2015/3/1

Y1 - 2015/3/1

UR - http://www.scopus.com/inward/record.url?scp=84940101393&partnerID=8YFLogxK

U2 - 10.2337/dc14-2517

DO - 10.2337/dc14-2517

M3 - Comment/debate

C2 - 25715413

AN - SCOPUS:84940101393

VL - 38

SP - 373

EP - 375

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 3

ER -